This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q63817778
rdf:type
wikibase:Item
schema:description
clinical trial ensayu clínicu կլինիկական փորձարկում klinisch onderzoek клінічне випробування
rdfs:label
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
skos:prefLabel
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
schema:name
Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.
p:P1476
wds:Q63817778-ABF87133-4B40-4580-8F1D-1630892CC8C6
wdt:P1476
A Randomized, Multi Center, Phase IIIb Open-label Study to Evaluate the Efficacy of Sequential Therapy of Peginterferon Alfa-2a(Pegasys(TM)) Following Entercavir Compared With Peginterferon Alfa-2a Monotherapy in Patient With HBeAg Positive Chronic Hepatitis B.
p:P582
wds:Q63817778-B6C793DD-18F1-4096-AF49-050861E74917
wdt:P582
2013-06-01T00:00:00Z
p:P31
wds:Q63817778-1ED3E9B2-FF6A-4382-8ABC-2883E4C66FF5
wdt:P31
wd:Q30612
p:P580
wds:Q63817778-A50539DF-7C00-47D7-8129-5052DE189DDE
wdt:P580
2010-06-01T00:00:00Z
p:P6153
wds:Q63817778-862DCEDE-D126-4C49-AC2E-E01851240F3F wds:Q63817778-CB834A98-FF06-41C8-AB31-914DD4860387 wds:Q63817778-9570A8EC-AB79-448F-A0C3-7B08E1A19374 wds:Q63817778-9BD771EE-E18C-4E87-B917-4AEB5859B41F wds:Q63817778-A96CCC6F-62F6-403B-9282-ED0E774CB571 wds:Q63817778-D3A76D4D-CA08-4BD5-A486-C88B68DCE94A wds:Q63817778-F06D9822-59A4-46F8-A771-3A8441F0368A wds:Q63817778-FB289415-5553-4E1C-8ECE-BFEB12E87AAB
wdt:P6153
wd:Q30280617 wd:Q496536 wd:Q43896415 wd:Q5587391 wd:Q12616442 wd:Q18648369 wd:Q22975296 wd:Q53122
p:P1813
wds:Q63817778-3869E8A4-7658-453F-A7FE-2A3B13857D9B
wdt:P1813
POTENT
p:P4844
wds:Q63817778-3EE82EE8-4F03-4BED-B61F-04F83B05367D
wdt:P4844
wd:Q20817235
p:P2899
wds:Q63817778-3A061BCF-7C53-4E0A-A664-83FCD4CFCF86
wdt:P2899
18
p:P1050
wds:Q63817778-70E9ED34-B88B-4870-A5A3-11450E1D498F wds:Q63817778-1EC63A89-F024-426E-B6A9-172023775CF1 wds:Q63817778-F24AE845-7D01-428D-B44F-6EC6FDBB2DC0
wdt:P1050
wd:Q157661 wd:Q6853 wd:Q131742
p:P1132
wds:Q63817778-502D22DA-E4F0-4ACB-A990-F707AF66B232
wdt:P1132
228
p:P8363
wds:Q63817778-ACD5AE7F-DE0F-40CC-8946-3CC7FD0B6A51
wdt:P8363
wd:Q78089383
p:P3098
wds:Q63817778-0C863FB0-64C8-45DD-87D8-EBB4EA453E6B
wdt:P3098
NCT01220596
p:P6099
wds:Q63817778-34194D7F-5816-4317-9C06-51B2BFAF9EA6
wdt:P6099
wd:Q42824827